Dopamine Selectively Inhibits the Direct Cortical Pathway to the CA1 Hippocampal Region
暂无分享,去创建一个
[1] R. Lubow. Latent inhibition. , 1973, Psychological bulletin.
[2] O. Vinogradova. Functional Organization of the Limbic System in the Process of Registration of Information: Facts and Hypotheses , 1975 .
[3] J. Nadler,et al. Baclofen selectively inhibits transmission at synapses made by axons of CA3 pyramidal cells in the hippocampal slice. , 1982, The Journal of pharmacology and experimental therapeutics.
[4] F. F. Weight,et al. Perforant pathway activation of hippocampal CA1 stratum pyramidale neurons: Electrophysiological evidence for a direct pathway , 1982, Brain Research.
[5] P. Calabresi,et al. Dopaminergic and noradrenergic responses in the hippocampal slice preparation Evidence for different receptors , 1984, Neuropharmacology.
[6] V. Gribkoff,et al. Modulation by dopamine of population responses and cell membrane properties of hippocampal CA1 neurons in vitro , 1984, Brain Research.
[7] S. Pockett. Dopamine changes the shape of action potentials in hippocampal pyramidal cells , 1985, Brain Research.
[8] R. Nicoll,et al. Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells , 1986, Brain Research.
[9] Gordon H. Bower,et al. Computational models of learning in simple neural systems , 1989 .
[10] G. Buzsáki. Two-stage model of memory trace formation: A role for “noisy” brain states , 1989, Neuroscience.
[11] W. Levy. A computational approach to hippocampal function , 1989 .
[12] P. Greengard,et al. Inhibition by dopamine of (Na+ + K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism , 1990, Nature.
[13] M. Yeckel,et al. Feedforward excitation of the hippocampus by afferents from the entorhinal cortex: redefinition of the role of the trisynaptic pathway. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] F. H. Lopes da Silva,et al. Anatomic organization and physiology of the limbic cortex. , 1990, Physiological reviews.
[15] M. Packard,et al. Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. , 1991, Behavioral neuroscience.
[16] M. Martres,et al. Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.
[17] Eric R. Marsh,et al. Do Central Antiadrenergic Actions Contribute to the Atypical Properties of Clozapine? , 1992, British Journal of Psychiatry.
[18] B. Bunney. Clozapine: A Hypothesised Mechanism for its Unique Clinical Profile , 1992, British Journal of Psychiatry.
[19] P. Calabresi,et al. Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum , 1992, Neuroscience Letters.
[20] W B Levy,et al. Electrophysiological and pharmacological characterization of perforant path synapses in CA1: mediation by glutamate receptors. , 1992, Journal of neurophysiology.
[21] B. McNaughton,et al. Computational approaches to hippocampal function , 1992, Current Biology.
[22] Coward Dm,et al. General pharmacology of clozapine. , 1992 .
[23] D. Coward,et al. General Pharmacology of Clozapine , 1992, British Journal of Psychiatry.
[24] M. LeMay,et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. , 1992, The New England journal of medicine.
[25] D. Surmeier,et al. D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons. , 1993, Progress in brain research.
[26] M. Sasa,et al. A mechanism underlying dopamine D1 and D2 receptor‐mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro , 1993, British journal of pharmacology.
[27] John O'Keefe,et al. Hippocampus, theta, and spatial memory , 1993, Current Opinion in Neurobiology.
[28] Enhancement of D2 receptor agonist‐induced inhibition by D1 receptor agonist in the ventral tegmental area , 1993, British journal of pharmacology.
[29] E. Kandel,et al. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. , 1993, Science.
[30] M. Hasselmo,et al. Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: computational modeling and brain slice physiology , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] B. Turetsky,et al. Frontal and temporal lobe brain volumes in schizophrenia: relationship to symptomatology and clinical subtype , 1994, Biological Psychiatry.
[32] J. Joyce,et al. Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase‐immunoreactive fibers , 1994, Hippocampus.
[33] H. Fibiger,et al. The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. , 1994, European journal of pharmacology.
[34] H. Meltzer,et al. An overview of the mechanism of action of clozapine. , 1994, The Journal of clinical psychiatry.
[35] L. Aguayo,et al. Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons. , 1994, The Journal of pharmacology and experimental therapeutics.
[36] J. Gray,et al. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET , 1995, Schizophrenia Research.
[37] Jeffrey A. Lieberman,et al. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia , 1995, Schizophrenia Research.
[38] R I Grossman,et al. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. , 1995, Archives of general psychiatry.
[39] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[40] A. Halberstadt. The phencyclidine-glutamate model of schizophrenia. , 1995, Clinical neuropharmacology.
[41] R. Empson,et al. Perforant path connections to area CA1 are predominantly inhibitory in the rat hippocampal‐entorhinal cortex combined slice preparation , 1995, Hippocampus.
[42] A. Carlsson. Neurocircuitries and neurotransmitter interactions in schizophrenia , 1995, International clinical psychopharmacology.
[43] G. Fein,et al. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: A 31Phosphorous magnetic resonance spectroscopic imaging study , 1995, Biological Psychiatry.
[44] R. Quirion,et al. Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[45] William B. Levy,et al. Another network model bites the dust: Entorhinal inputs are no more than weakly excitatory in the hippocampal CA1 region , 1995, Hippocampus.
[46] K. Takenouchi,et al. Shortening of the hippocampal formation in first‐episode schizophrenic patients , 1995, Psychiatry and clinical neurosciences.
[47] M. Buchsbaum,et al. Structural and functional correlates of subsyndromes in chronic schizophrenia. , 1995, Psychopathology.
[48] P. Somogyi,et al. High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus , 1995, Neuroscience.
[49] Richard S. J. Frackowiak,et al. A functional neuroanatomy of hallucinations in schizophrenia , 1995, Nature.
[50] C. Gerfen,et al. D1–D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression , 1995, Neuroscience.
[51] J. Gorman,et al. Reality monitoring failure in schizophrenia: The role of selective attention , 1996, Schizophrenia Research.
[52] J. Lisman,et al. D1/D5 Dopamine Receptor Activation Increases the Magnitude of Early Long-Term Potentiation at CA1 Hippocampal Synapses , 1996, The Journal of Neuroscience.
[53] K. Hsu,et al. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. , 1996, Journal of neurophysiology.
[54] É. Hajós‐Korcsok,et al. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. , 1996, European journal of pharmacology.
[55] S. Sesack,et al. Hippocampal afferents to the rat prefrontal cortex: Synaptic targets and relation to dopamine terminals , 1996, The Journal of comparative neurology.
[56] Glutamate receptors and schizophrenia: opportunities and caveats. , 1996 .
[57] P. Perruchet,et al. Implicit and explicit associative memory in patients with schizophrenia , 1996, Schizophrenia Research.
[58] M. Munetz. Contemporary Issues in the Treatment of Schizophrenia , 1996 .
[59] P. Goldman-Rakic,et al. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.
[60] T. Kaneko,et al. Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody , 1996, Neuroscience Letters.
[61] N. Swerdlow,et al. Do D1/D2 Interactions Regulate Prepulse Inhibition in Rats? , 1996, Neuropsychopharmacology.
[62] J. Lisman,et al. Physiologically realistic formation of autoassociative memory in networks with theta/gamma oscillations: role of fast NMDA channels. , 1996, Learning & memory.
[63] J. Brioni,et al. Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat , 1996, Neuroscience.
[64] D. Javitt. Glutamate receptors and schizophrenia: opportunities and caveats. , 1996, Molecular psychiatry.
[65] O. Pongs,et al. Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[66] B. Bunney,et al. D1–D2 Interaction in Feedback Control of Midbrain Dopamine Neurons , 1997, The Journal of Neuroscience.
[67] M. Smith,et al. Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor. , 1997, European journal of pharmacology.
[68] R. Hampson,et al. The significance of neural ensemble codes during behavior and cognition. , 1997, Annual review of neuroscience.
[69] F. J. White,et al. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors , 1997, Neuroscience Letters.
[70] M. Millan,et al. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. , 1997, European journal of pharmacology.
[71] E. Malchiodi,et al. Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. , 1997, Brain research. Molecular brain research.
[72] H Eichenbaum,et al. Declarative memory: insights from cognitive neurobiology. , 1997, Annual review of psychology.
[73] I Izquierdo,et al. Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[74] S. Sesack,et al. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum , 1997, Brain Research.
[75] R. Bernabeu,et al. Involvement of hippocampal D1/D5 receptor-cAMP signaling pathways in a late memory consolidation phase of an aversively-motivated task in rats , 1997 .
[76] J. Meador-Woodruff,et al. Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia , 1997, Neuropsychopharmacology.
[77] F. H. Lopes da Silva,et al. Nucleus Reuniens Thalami Modulates Activity in Hippocampal Field CA1 through Excitatory and Inhibitory Mechanisms , 1997, The Journal of Neuroscience.
[78] Andreas Lüthi,et al. Modulation of AMPA receptor unitary conductance by synaptic activity , 1998, Nature.
[79] S. Sesack,et al. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.
[80] J. Lisman,et al. D1/D5 Dopamine Receptors Inhibit Depotentiation at CA1 Synapses via cAMP-Dependent Mechanism , 1998, The Journal of Neuroscience.
[81] G. Barrionuevo,et al. Electrophysiological and pharmacological characterization of the direct perforant path input to hippocampal area CA3. , 1998, Journal of neurophysiology.
[82] N. Alpert,et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia , 1998, Nature Neuroscience.